Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

John J Cush (Author), Kathryn H. Dao (Author)

9781455750658, Elsevier Health Sciences

Hardback, published 19 November 2012

240 pages
28 x 19 x 2.1 cm, 0.46 kg

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Subject Areas: Rheumatology [MJM]